Blindness Terminated Phase Trials for Melatonin (DB01065)

Also known as: Blind / Blindness NOS

IndicationStatusPhase
DBCOND0009476 (Blindness)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00795236Melatonin Studies of Totally Blind ChildrenTreatment
NCT00691444Blind Child Melatonin Treatment StudyTreatment
NCT00692094Blind Elderly Melatonin Treatment StudyTreatment
NCT00688935Young Blind Child Melatonin Treatment StudyDiagnostic
NCT00911053Melatonin for Circadian Sleep Disorders in the BlindTreatment